Compare Mulia Industrindo Tbk (MLIA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mulia Industrindo Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Mulia Industrindo Tbk trades at Rp240 (market cap 1.59T, 23.4K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 7.1× Mulia Industrindo Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 23.4K). Which is the better fit depends on your goals.
| MLIA | TSPC | |
|---|---|---|
Market Cap | 1.59T | 11.36T |
Volume | 23.4K | 1.77M |
Lot | 234 | 17.71K |
Turnover | 5.6M | 4.61B |
Average Price | 239.28 | 2,603.9 |
Value | 5.6M | 4.61B |
Indicative Equilibrium Price | 240 | 2,590 |
Indicative Equilibrium Volume | 11 | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mulia Industrindo Tbk
PT Mulia Industrindo Tbk (the company) was established based on Deed No. 15 dated November 5, 1986 of Liliani Handajawati Tamzil S.H., notary in Jakarta, as amended by deed No. 7 dated May 6, 1987 of the same notary.. The company's articles of association have been amended several times, most recently on January 21, 1997 regarding the change of the Company's name and par value per share. The company is one of the companies of the Mulia Group. The company started its commercial operations in 1990.
Read more on MLIA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
